- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Focus Articles
- Related Articles1 new
- Instablogs
- StockTalks
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
RMD Market Currents
more »
-
April 27 ResMed (RMD +7%) trades up after beating FQ3 consensus estimates late yesterday. Net income jumped 21% Y/Y, driven by higher-than-expected gross margins from strong growth in masks and a shift to higher-margin flow generators. Separately, Goldman ups the shares to Buy on the back of the blowout quarter.
Comment![Healthcare, Earnings, On the Move]
RMD Related Articles
more »
RMD News
more »
-
at MarketWatch.com (May 18, 2012)
-
at CNBC.com (Jan 27, 2012)
-
at MarketWatch.com (May 5, 2011)
-
at CNBC.com (Feb 2, 2011)
-
at CNBC.com (Feb 1, 2011)
RMD Press Releases and Filings
more »
-
PR Newswire (Wed, 4:00PM)
-
PR Newswire (May 17, 2012)
-
PR Newswire (Apr 26, 2012)
-
PR Newswire (Apr 11, 2012)
-
PR Newswire (Mar 26, 2012)
RMD Latest Transcript
more »
-
Fri, May 11Popular searches: australia.
RMD Cramer
more »
-
Fri, Jun 5, 2009
-
Wed, Jul 2, 2008
-
Tue, Jul 11, 2006
RMD Instablog posts
more »
RMD vs. ETF Alternatives
Company Description
We are a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing, or SDB, includes obstructive sleep apnea, or OSA, and other respiratory disorders that... More
